The self-expanding valve is not yet approved by the FDA, but care teams in other markets are reporting positive outcomes when patients go home the day after treatment. 

Jim Melton, DO, a vascular surgeon in Oklahoma City, explains his efforts to reach patients in rural Oklahoma and Native American tribes with a mobile cardiovascular clinic program.

Patients with pulmonary hypertension are associated with increased short- and long-term risks of death following TAVR. Researchers emphasized the importance of learning as much as possible about this topic going forward. 

The new-look PFA system from Pulse Biosciences was designed to treat AFib with a single application that lasts less than two seconds.

Electrophysiology specialist Vivek Reddy, MD, and colleagues reviewed data from more than 17,000 patients, presenting their findings in Nature Medicine.

Impella heart pumps may not provide as much value when treating high-risk patients as early data suggested.

A new study of nearly 300 PCI patients suggests biolimus-coated balloons could provide significant value to interventional cardiologists in the years ahead.  

Some care teams have turned to a more active follow-up strategy for high-risk PCI patients—but it may not provide much value.